Assessment of four monoclonal antibodies as serum markers in breast cancer
- 31 December 1990
- journal article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 26 (11-12), 1127-1132
- https://doi.org/10.1016/0277-5379(90)90268-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- CA15-3: Its relationship to clinical stage and progression to metastatic disease in breast cancerBritish Journal of Surgery, 1989
- Serum CA 15-3 assay in the diagnosis and follow-up of breast cancerBritish Journal of Cancer, 1988
- Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancerBritish Journal of Cancer, 1987
- Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinomaBritish Journal of Cancer, 1987
- Value of CA 15:3 in the follow-up of breast cancer patientsBritish Journal of Cancer, 1987
- Detection of the tumour‐associated antigens recognized by the monoclonal antibodies hmfg‐1 and 2 in serum from patients with breast cancerInternational Journal of Cancer, 1984
- A monoclonal antibody, NCRC‐11, raised to human breast carcinoma. 1. Production and immunohistological characterizationHistopathology, 1984
- Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancersInternational Journal of Cancer, 1981
- Monoclonal antibodies to epithelium‐specific components of the human milk fat globule membrane: Production and reaction with cells in cultureInternational Journal of Cancer, 1981
- DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUESThe Journal of Experimental Medicine, 1965